Phase II Trial of Vorinostat plus Tacrolimus and Mycophenolate to Prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant

Show simple item record

dc.contributor.author Choi, Sung Won
dc.contributor.author Reddy, Pavan
dc.date.accessioned 2013-10-21T23:21:19Z
dc.date.available 2013-10-21T23:21:19Z
dc.date.issued 2013-10-21
dc.identifier.uri http://hdl.handle.net/2027.42/100248
dc.description UMCC 2008.095 Protocol en_US
dc.description.sponsorship FUNDING Merck and Co., Inc., Leukemia and Lymphoma Society, National Institutes of Health (R01CA143379, 1K23AI091623, P01CA039542, P30CA047904, R01AI15614), St. Baldrick’s Foundation, and Michigan Institute for Clinical and Health Research UL1TR00043. en_US
dc.language.iso en_US en_US
dc.subject GVHD Vorinostat HDAC Inhibition Allogeneic HSCT Reduced Intensity Conditioning en_US
dc.title Phase II Trial of Vorinostat plus Tacrolimus and Mycophenolate to Prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant en_US
dc.type Other en_US
dc.subject.hlbsecondlevel Pediatrics
dc.subject.hlbtoplevel Health Sciences
dc.contributor.affiliationum Pediatrics and Communicable Diseases en_US
dc.contributor.affiliationum Internal Medicine en_US
dc.contributor.affiliationumcampus Ann Arbor en_US
dc.description.bitstreamurl http://deepblue.lib.umich.edu/bitstream/2027.42/100248/1/umcc_2008 095_protocol.pdf
dc.owningcollname Pediatrics and Communicable Diseases, Department of
 Show simple item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Available Now


MLibrary logo